Drug Trial Radar · NCT01347710
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Last checked: Nov 20, 2026Latest source record: Nov 24, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
795
Actual
Start
Jun 2011
Primary completion
Jul 2013
Study completion Sep 2013
Sponsor
- Lead sponsor
- Lantheus Medical ImagingIndustry
- Sponsor type
- Industry
- First posted
- May 4, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the study is to assess the diagnostic efficacy (specificity and sensitivity) of flurpiridaz F18 injection PET myocardial perfusion imaging (MPI) compared to single photon emission computed tomography (SPECT) MPI in the detection of significant coronary artery disease (CAD) as defined by invasive coronary angiography (ICA) or a documented history of Myocardial Infarction (MI).
Conditions
- Coronary Artery Disease
Interventions
Flurpiridaz F18Drug
Injection of Flurpiridaz F18 for the purposes of PET myocardial profusion imaging (MPI) analysis
99mTechnicium (sestamibi or tetrofosmin)Drug
Injection of 99mTc sestamibi or tetrofosmin for the purposes of SPECT MPI analysis
Primary outcomes
What the sponsor says the trial is designed to measure.
- Diagnostic Efficacy of Flurpiridaz F 18 PET Myocardial Perfusion Imaging (MPI) Sensitivity Versus SPECT Myocardial Perfusion Imaging SensitivityTime frame: 60 days
- Diagnostic Efficacy of Flurpiridaz PET MPI Specificity Versus SPECT MPI SpecificityTime frame: 60 days
Locations
81 sites in 4 countries. Site status is shown where the registry gives one.
Cardiology Associates of Mobile, Inc.
Mobile, Alabama
Scottsdale Medical Imaging, Ltd.
Scottsdale, Arizona
West Side Medical Associates of Los Angeles
Beverly Hills, California
USC PET Imaging Science Center
Los Angeles, California
Cedars-Sinai Medical Center
Los Angeles, California
VA West Los Angeles Medical Center
Los Angeles, California
UCLA
Los Angeles, California
Veterans Affairs Palo Alto Health Care System
Palo Alto, California
Cardiovascular Consultants Medical Group
Pleasant Hill, California
Northern California PET Imaging Center-Palo Alto
Sacramento, California
VA San Diego Healthcare System
San Diego, California
UCSF Medical Center
San Francisco, California
Yale University
New Haven, Connecticut
Alfieri Cardiology
Newark, Delaware
Christiana Care Health System
Newark, Delaware
Elite Research and Clinical Trials
Aventura, Florida
Independent Imaging, LLC
Boynton Beach, Florida
Coastal Cardiology Consultants dba The Heart & Vascular Institute of Florida
Clearwater, Florida
Florida Heart Associates
Fort Myers, Florida
St. Luke's Cardiology Associates
Jacksonville, Florida
The Cardiovascular Center, PA
Lake Mary, Florida
Florida Hospital/Cardiovascular Institute (Florida Heart Group)
Orlando, Florida
South Florida Research Solutions
Pembroke Pines, Florida
Memorial Hospital of Tampa
Tampa, Florida
Georgia Health Sciences Univ/Med College of GA
Augusta, Georgia
South Coast Imaging Center
Savannah, Georgia
Gateway Cardiology, PC
Jerseyville, Illinois
Norton Cardiovascular Associates
Louisville, Kentucky
Biomedical Research Foundation of Northwest Louisiana
Shreveport, Louisiana
Maine Research Associates
Auburn, Maine
Johns Hopkins University
Baltimore, Maryland
Mass General Hospital (MGH)
Boston, Massachusetts
Boston University Medical Center
Boston, Massachusetts
University of Michigan Health System
Ann Arbor, Michigan
Wayne State University - Harper University Hospital
Detroit, Michigan
Henry Ford Hospital
Detroit, Michigan
St. Mary's Healthcare (Trinity Health)
Grand Rapids, Michigan
McLaren Macomb
Mount Clemens, Michigan
William Beaumont Hospital
Royal Oak, Michigan
Hattiesburg Clinic
Hattiesburg, Mississippi
Showing 40 of 81 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.